Production of the Aston Martin DBX707 has been delayed, with new orders in Australia unlikely to arrive until the end of this year.
The Aston Martin DBX707 is running behind schedule, with production pushed back at least a month – and new Australian orders are unlikely to arrive until the end of this year.
Aston Martin previously announced production of its flagship SUV was “due to commence in Q1 [between January and March] 2022.”
However, the first customer examples did not roll off the brand’s factory floor in Wales until Tuesday last week (9 May 2022.)
The brand originally said its DBX707 was on track to arrive in local showrooms in April or May 2022.
Drive understands an initial shipment is now due to arrive in July, approximalty two or three months after originally promised.
A spokesperson for Aston Martin in Australia said the arrival timing has not changed, and claimed an incorrect estimate was originally provided.
According to Australian dealerships canvassed by Drive, local buyers who place an order for an Aston Martin DBX707 today will likely wait at least six months for a vehicle.
It’s unclear what has caused production delays, however most car manufacturers have struggled with parts shortages over the past 18 months due to the semiconductor crisis.
A 4.0-litre twin-turbo V8 in the DBX707 sends 520kW/900Nm to all four wheels via nine-speed transmission – making it the most powerful petrol SUV in the world.
This allows the 0-100km/h sprint to be completed in a claimed 3.3 seconds, on the way to a supercar-rivalling top speed of 311km/h.
Other updated features over the standard DBX include 22- or 23-inch alloy wheels, air suspension, carbon-ceramic discs, and a launch control system.
The Aston Martin DBX707 will start from $428,400 before on-road costs in Australia – a premium of $53,502 over the lesser V8 variant.
Despite primarily building coupes throughout its 109 year history, Aston Martin pulled the covers of its DBX SUV in 2019.
It’s since become the brand’s most popular model, representing roughly 50 per cent of all sales and driving record deliveries in 2021.
Despite increased volume however, the brand continues to struggle financially and announced a net debt of £956.8 million earlier this year.
Drive understands the current Formula One DBX medical car will be converted to the faster 707 variant later this year.